As policymakers search for potential cuts to the national budget, they risk jeopardizing the country's most cost-effective use of healthcare dollars: biomedical innovation regarding vaccines, prescription drugs, and emerging therapies, including antibodies. As the nation rapidly ages, protecting…
Read Full Article »

